|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 85, 284-286, Copyright © 1984 by American College of Chest Physicians
ARTICLES |
J Joelson, J Kluger, S Cole and M Conway
Amiodarone hydrochloride, a new antiarrhythmic agent, has been associated with pulmonary toxicity characterized by cough, dyspnea and diffuse pulmonary infiltrates. We describe a case of fibrosing alveolitis, diagnosed by lung biopsy, in a patient receiving amiodarone which responded to corticosteroid therapy. The pulmonary symptoms recurred after discontinuing corticosteroids, five months after amiodarone was stopped, and were associated with a persistent amiodarone level. To our knowledge, this recurrence of amiodarone pulmonary toxicity has not been reported previously.
This article has been cited by other articles:
![]() |
L. J. Faling and E. J. Mark Case 35-1997- A 65-Year-Old Woman with a Dry Cough and Pulmonary Nodules N. Engl. J. Med., November 13, 1997; 337(20): 1449 - 1458. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |